Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "insect"

23 News Found

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Opinion | June 01, 2026

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms


WHO prequalifies Syngenta’s innovative insecticide Sovrenta
News | April 23, 2025

WHO prequalifies Syngenta’s innovative insecticide Sovrenta

A new weapon in the global fight against malaria


DENSTAR project launched to fast-track dengue vaccine licensure in Africa
Healthcare | June 09, 2026

DENSTAR project launched to fast-track dengue vaccine licensure in Africa

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa


Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
Medical Device | June 05, 2026

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections


Ahmedabad hosts national conclave on urban pest and vector control strategies
Policy | April 28, 2026

Ahmedabad hosts national conclave on urban pest and vector control strategies

Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
Biotech | April 20, 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols


Bayer welcomes the U.S. Supreme Court decision to review Durnell case in the Roundup litigation
News | January 17, 2026

Bayer welcomes the U.S. Supreme Court decision to review Durnell case in the Roundup litigation

Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy


Bayer welcomes US Solicitor General’s support as Supreme Court weighs Roundup case
News | December 02, 2025

Bayer welcomes US Solicitor General’s support as Supreme Court weighs Roundup case

At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits


Vivo Bio Tech secures pre-clinical testing contract valued at Rs.10.75 Cr
News | August 22, 2025

Vivo Bio Tech secures pre-clinical testing contract valued at Rs.10.75 Cr

Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies